Consolidated figures · ₹ crore
| ₹ Cr | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| 4,093 | 3,731 | 5,081 | 5,428 | 4,726 | 5,583 | 6,274 | |
| COGS | 1,970 | 1,695 | 2,589 | 2,864 | 2,511 | 2,746 | 3,306 |
| Gross profit | 2,123 | 2,036 | 2,492 | 2,564 | 2,215 | 2,838 | 2,967 |
| 1,216 | 1,112 | 1,581 | 1,789 | 1,578 | 1,913 | 1,937 | |
| 907 | 924 | 911 | 775 | 637 | 924 | 1,031 | |
| OPM % | 22.2% | 24.8% | 17.9% | 14.3% | 13.5% | 16.6% | 16.4% |
| Depreciation | 130 | 136 | 177 | 198 | 243 | 317 | 322 |
| Interest | 9 | 9 | 9 | 8 | 11 | 24 | 17 |
| 78 | 103 | 84 | 119 | 68 | 109 | 209 | |
| Profit before tax | 845 | 882 | 810 | 688 | 451 | 692 | 915 |
| Tax | 175 | 222 | 205 | 181 | 127 | 194 | 225 |
| Tax % | 20.6% | 25.1% | 25.3% | 26.3% | 28.1% | 28% | 24.6% |
| 671 | 660 | 605 | 507 | 324 | 499 | 689 | |
| PAT margin % | 16.4% | 17.7% | 11.9% | 9.3% | 6.9% | 8.9% | 11% |
| EPS (₹) | 224.7 | 221.2 | 204.2 | 174.2 | 109.5 | 164.4 | 230.3 |
| EPS adjusted (₹) | 224.6 | 25.7 | 204.1 | -30 | 109.7 | 164.3 | 230.1 |
| 12.2% | 9% | 15.9% | 14.4% | 18.3% | 15.2% | 13% | |
| Annual report | Annual report for Mar 2020 | Annual report for Mar 2021 | Annual report for Mar 2022 | Annual report for Mar 2023 | Annual report for Mar 2024 | Annual report for Mar 2025 | Annual report for Mar 2026 |
| ₹ Cr | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|
| Equity capital | 30 | 30 | 30 | 30 | 29 | 29 | 29 |
| Reserves | — | 3,797 | 4,399 | 4,642 | 5,085 | 5,569 | 6,193 |
| Minority interest | — | 31 | 31 | 48 | 49 | 64 | 75 |
| — | 102 | 138 | 47 | 228 | 198 | 180 | |
| — | 978 | 1,108 | 1,002 | 1,085 | 1,141 | 1,424 | |
| Total equity & liabilities | — | 4,937 | 5,706 | 5,768 | 6,476 | 7,001 | 7,900 |
| 1,107 | 1,399 | 1,613 | 1,747 | 2,768 | 2,823 | 2,650 | |
| CWIP | — | 250 | 420 | 1,033 | 281 | 124 | 110 |
| Investments | — | 1,364 | 1,342 | 884 | 1,395 | 1,769 | 2,595 |
| — | 1,925 | 2,331 | 2,104 | 2,032 | 2,285 | 2,545 | |
| Total assets | — | 4,937 | 5,706 | 5,768 | 6,476 | 7,001 | 7,900 |
As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.
Latest reported period · 31 Mar 2026 · ₹ crore
| Segment | Revenue | Result | Assets | Liabilities | Capital employed | ROCE % |
|---|---|---|---|---|---|---|
| Performance and Other Chemicals | 4,608.73 | 85.51 | 3,861.45 | 924.58 | 2,936.87 | 2.91 |
| Life Science Chemicals | 1,805.24 | 417.06 |
| ₹ Cr | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| 718 | 231 | 707 | 667 | 603 | 1,023 | |
| -646 | -168 | -469 | -683 | -495 | -895 | |
| -52 | -57 | -257 | 38 | -84 | -98 | |
| Net cash flow | 19 | 6 | -20 | 22 | 24 | 30 |
| Free cash flow | 395 | -359 | -168 | 164 | 333 | 848 |
| CFO / Operating profit % | 78.3% | 25.4% | 91.2% | 104.8% | 66.1% | 99.2% |
| 1,379.25 |
| 305.45 |
| 1,073.8 |
| 38.84 |
| Others | 80.39 | 11.84 | 240.92 | 21.33 | 219.59 | 5.39 |
₹ crore by fiscal year